Catalyst Wire Dossier Catalyst Wire Dossier

ABT-888

veliparib · Abbott Laboratories
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for ABT-888, covering 2012-03-15 to 2021-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer [Phase 3]

See pricing